Educational Videos
Expand your knowledge about CAR T-cell therapies and autoimmune diseases from scientist and patient perspectives.
Spotlight on Autoimmunity: KYSA-1 Phase 1 Trial of KYV-101 in Refractory Lupus Nephritis
Learn more about KYSA-1, an open-label, Phase 1/2 clinical trial of KYV-101, an anti-CD19 chimeric antigen receptor (CAR) T-cell therapy